Publication date: Jun 25, 2025
Hybrid fiber-reinforced polymer (FRP) and steel reinforced concrete (hybrid FRP-steel RC) beams have gained recognition for their exceptional flexural performance, surpassing that of beams reinforced exclusively with FRP bars (FRP-RC). However, current design guidelines, such as ACI 440. 11-22, fail to accurately predict the flexural strength of these hybrid systems. This study aims to enhance the predictive accuracy and interpretability of flexural strength models by applying advanced computational approaches-specifically, machine learning (ML) techniques and symbolic regression. A robust dataset of 134 experimental data points was utilized to develop predictive models. The prediction results showed that both ML and symbolic regression models significantly outperformed the ACI 440. 11-22 equations, achieving lower errors (MAE, MAPE, RMSE) and higher accuracy (R). The results demonstrate that the ML models-Gaussian process regression (GPR), NGBoost, and CatBoost-achieved high predictive accuracy, with mean R values approaching 1. 0 and MAPE% as low as 5. 19 (training) and 11. 51 (testing) for GPR. Furthermore, symbolic regression yielded a transparent mathematical expression with a mean prediction ratio (u) of 1. 003, a CoV of 0. 139, and a MAPE% of 11. 08. These findings highlight the practical and technical advantages of symbolic regression in developing reliable, interpretable, and efficient design equations for hybrid FRP-steel RC beams.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Catboost | CatBoost model |
| Efficient | Fiber-reinforced polymer |
| Flexural | Flexural strength |
| Mathematical | Machine learning |
| Outperformed | Symbolic regression |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | IDO | process |
| drug | DRUGBANK | Coenzyme M |
| drug | DRUGBANK | Spinosad |
| drug | DRUGBANK | Tricyclazole |
| drug | DRUGBANK | Flunarizine |
| disease | IDO | algorithm |
| disease | MESH | uncertainty |
| drug | DRUGBANK | Medroxyprogesterone acetate |
| drug | DRUGBANK | Isoxaflutole |
| disease | MESH | mutation rate |
| drug | DRUGBANK | (S)-Des-Me-Ampa |
| drug | DRUGBANK | Nonoxynol-9 |
| pathway | REACTOME | Reproduction |